According to Cormedix's latest financial reports the company has $70.14 M in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $70.14 M | 27.39% |
2022-12-31 | $55.05 M | -12.32% |
2021-12-31 | $62.79 M | 42% |
2020-12-31 | $44.22 M | 87.02% |
2019-12-31 | $23.64 M | 379.23% |
2018-12-31 | $4.93 M | -31.41% |
2017-12-31 | $7.19 M | -59.62% |
2016-12-31 | $17.81 M | -47.62% |
2015-12-31 | $34.01 M | 835.8% |
2014-12-31 | $3.63 M | -190.36% |
2013-12-31 | $-4.03 M | 1099.35% |
2012-12-31 | $-0.34 M | -125.19% |
2011-12-31 | $1.33 M | -81.65% |
2010-12-31 | $7.25 M | -149.33% |
2009-12-31 | $-14.71 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Becton Dickinson BDX | $25.33 B | 36,016.53% | ๐บ๐ธ USA |
Utah Medical Products UTMD | $0.12 B | 82.93% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | $0.64 B | 825.69% | ๐บ๐ธ USA |